<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on 5AM Ventures from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated 5AM Ventures news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 01:55:02 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=5AM+Ventures" rel="self" type="application/rss+xml" />

	
<item><title>State invests $3 million in bioscience fund</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038899&amp;HITNO=0&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038899&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537827787%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038899&amp;HITNO=0&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038899&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537827787%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Orlando Sentinel:</description></item>
<item><title>State fund to invest $3 million with Silicon Valley firm for bioscience capital</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037080&amp;HITNO=1&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037080&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536900053%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037080&amp;HITNO=1&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037080&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536900053%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Orlando Sentinel:</description></item>
<item><title>Pearl Therapeutics secures $15 million in financing</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010028&amp;HITNO=2&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010028&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522202570%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010028&amp;HITNO=2&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010028&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522202570%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Workers are protesting at Johnson &amp; JohnsonEURs decision to scrap 500 jobs at its Janssen Pharmaceutica plan</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4004498&amp;HITNO=3&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4004498&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519989532%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4004498&amp;HITNO=3&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4004498&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519989532%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>VRT Nieuws:</description></item>
<item><title>Pearl Advancing Inhaled Combo COPD Product with $15M Round</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3995217&amp;HITNO=4&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3995217&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2515540005%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3995217&amp;HITNO=4&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3995217&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2515540005%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Pearl Therapeutics Raises $</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3992873&amp;HITNO=5&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3992873&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2514365935%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3992873&amp;HITNO=5&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3992873&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2514365935%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioSpace:</description></item>
<item><title>Pearl Therapeutics Raises $15 Million to Advance PT003, LAMA/LABA Combination Bronchodilator for COPD, Into Ph</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991879&amp;HITNO=6&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991879&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513908811%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991879&amp;HITNO=6&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991879&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513908811%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioSpace:</description></item>
<item><title>Flexion lands $42M, acquires drug targets</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3988307&amp;HITNO=7&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3988307&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510892987%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3988307&amp;HITNO=7&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3988307&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510892987%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Charlotte Business Journal:</description></item>
<item><title>Going Beyond the 'Chorus' Line; Flexion Accelerates Clinical POC</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3987749&amp;HITNO=8&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3987749&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510056956%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3987749&amp;HITNO=8&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3987749&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510056956%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioWorld:</description></item>
<item><title>Going Beyond the 'Chorus' Line; Flexion Accelerates Clinical POC</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986632&amp;HITNO=9&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986632&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2509291930%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986632&amp;HITNO=9&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986632&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2509291930%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Flexion Therapeutics Raises $9 Million</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984016&amp;HITNO=10&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984016&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2507988131%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984016&amp;HITNO=10&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984016&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2507988131%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Private Equity HUB:</description></item>
<item><title>Flexion Snags Pfizer Bucks, Three Pharma Deals, For New Drug Model</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3981099&amp;HITNO=11&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3981099&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506770830%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3981099&amp;HITNO=11&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3981099&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506770830%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Xconomy:</description></item>
<item><title>Flexion lands $42M, acquires drug targets</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985664&amp;HITNO=12&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985664&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508730948%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985664&amp;HITNO=12&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985664&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508730948%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Houston Business Journal:</description></item>
<item><title>Flexion lands $42M, acquires drug targets</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985389&amp;HITNO=13&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985389&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508598424%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985389&amp;HITNO=13&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985389&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508598424%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Francisco Business Times:</description></item>
<item><title>Flexion lands $42M, acquires drug targets</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985377&amp;HITNO=14&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985377&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508593570%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985377&amp;HITNO=14&amp;MSIZE=24&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=5AM%20Ventures&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985377&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508593570%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Boston Business Journal:</description></item>
</channel></rss>